16th Oct 2020 10:56
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 15 October 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,613,936 | 2.03% | 467,354 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
544,656 | 0.42% | 438,524 | 0.34% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,158,592 | 2.45% | 905,878 | 0.70% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 15 | 215.6500 USD |
| Purchase | 30 | 210.6800 USD |
| Purchase | 60 | 215.3858 USD |
| Purchase | 76 | 215.7822 USD |
| Purchase | 98 | 215.6481 USD |
| Purchase | 100 | 211.2900 USD |
| Purchase | 104 | 215.9919 USD |
| Purchase | 114 | 215.2622 USD |
| Purchase | 154 | 214.6063 USD |
| Purchase | 226 | 215.6954 USD |
| Purchase | 279 | 216.5900 USD |
| Purchase | 282 | 215.6777 USD |
| Purchase | 303 | 216.4119 USD |
| Purchase | 356 | 215.7297 USD |
| Purchase | 477 | 215.9793 USD |
| Purchase | 555 | 216.2790 USD |
| Purchase | 1,035 | 216.1455 USD |
| Purchase | 1,268 | 212.6784 USD |
| Purchase | 1,509 | 216.3408 USD |
| Purchase | 1,633 | 216.1404 USD |
| Purchase | 1,733 | 216.0841 USD |
| Purchase | 2,013 | 216.1770 USD |
| Purchase | 2,593 | 216.2227 USD |
| Purchase | 2,662 | 216.1819 USD |
| Purchase | 3,071 | 215.6125 USD |
| Purchase | 3,076 | 216.1215 USD |
| Purchase | 3,613 | 216.1585 USD |
| Purchase | 4,597 | 216.6200 USD |
| Purchase | 7,388 | 216.1729 USD |
| Purchase | 9,100 | 216.0907 USD |
| Purchase | 9,621 | 215.5544 USD |
| Purchase | 14,507 | 216.5546 USD |
| Purchase | 21,419 | 216.2183 USD |
| Purchase | 22,502 | 215.6244 USD |
| Purchase | 27,224 | 215.8209 USD |
| Sale | 5 | 216.0600 USD |
| Sale | 30 | 210.6800 USD |
| Sale | 70 | 209.9900 USD |
| Sale | 100 | 211.2900 USD |
| Sale | 112 | 216.3146 USD |
| Sale | 191 | 213.8842 USD |
| Sale | 499 | 216.4488 USD |
| Sale | 525 | 216.5246 USD |
| Sale | 668 | 215.8456 USD |
| Sale | 714 | 215.3228 USD |
| Sale | 790 | 216.3718 USD |
| Sale | 800 | 216.1583 USD |
| Sale | 1,134 | 214.5879 USD |
| Sale | 1,163 | 216.0689 USD |
| Sale | 1,268 | 212.6784 USD |
| Sale | 1,270 | 215.3585 USD |
| Sale | 1,699 | 216.3468 USD |
| Sale | 1,859 | 215.6626 USD |
| Sale | 2,291 | 214.4131 USD |
| Sale | 7,518 | 215.7353 USD |
| Sale | 8,211 | 216.3647 USD |
| Sale | 8,473 | 216.0440 USD |
| Sale | 8,536 | 215.6037 USD |
| Sale | 8,757 | 215.6775 USD |
| Sale | 11,735 | 216.6200 USD |
| Sale | 24,765 | 215.8417 USD |
| Sale | 50,009 | 216.1925 USD |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
|
| unit | |
| SWAP | Short | 50,000 | 216.2225 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 16 Oct 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20201016005280/en/
Copyright Business Wire 2020
Related Shares:
Barclays